
Co-located with

Into its 9th edition, Cell and Gene Therapy World Asia has firmly established itself as Asia's THE cell and gene therapy gathering for new partnerships, ideas and knowledge. We are proud to continue the meeting platform where Asia's growing cell and gene therapy industry is at the forefront, receiving more and more global attention on its fast advancement in new therapies, R&D and biomanufacturing.
Key Themes & Topics
What to Expect at the 9th Annual Cell & Gene Therapy World Asia 2025

Attendees
Join over 500 professionals at the 9th Annual Cell & Gene Therapy World Asia! This is your chance to connect with key industry players, expand your network, and engage in high-level discussions that will shape the future of biologics.

Companies
Meet 150 leading companies driving innovation in the biologics sector. Whether you're looking for new partners or exploring the latest breakthroughs, this is the perfect platform to discover what’s next in the industry.

Speakers
Gain exclusive insights from 50 expert speakers who are shaping the future of biologics. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you can’t afford to miss.
Testimonials
Into its 9th edition, Cell and Gene Therapy World Asia has firmly established itself as Asia's THE cell and gene therapy gathering for new partnerships, ideas and knowledge. We are proud to continue the meeting platform where Asia's growing cell and gene therapy industry is at the forefront, receiving more and more global attention on its fast advancement in new therapies, R&D and biomanufacturing.
WHO
C-Suites, Heads, Presidents, Directors, VPs, of R&D, Process Development and Manufacturing, Cell & Gene Therapy, Regenerative Medicines, Quality Control and Assurance from Cell & Gene Therapy Companies from Asia and the rest of the World.
WHAT
Evaluate the best practices, latest strategies, technologies and solutions in building a quality cell & gene therapy treatments through Asia's clinical trials and markets.
WHY
The Asia-Pacific (APAC) region played a substantial role in the global revenue of Cell and Gene Therapies (CGT), contributing over 26% in 2021. Projections indicate a robust expansion with a compound annual growth rate (CAGR) of 21% from 2021 to 2027, culminating in a market size of US$4 billion. Additionally, the Cell & Gene Biomanufacturing sector is poised for remarkable growth, with an expected CAGR of 17.88% from 2022 to 2031, witnessing a substantial increase from $1.96 billion to an impressive $8.60 billion. Notably, significant investments from governments, pharmaceutical leaders, and academic institutions in the APAC region are paving the way for innovative breakthroughs in medical treatments, fostering an increased demand for advanced biomanufacturing solutions.
CONTACT
Ana Laxamana, Business Development Manager
m: +65 6983 6132
Nathan Grace Niño, Business Development Manager
m: +65 6983 6134 | +44 161 552 8521

Share With Your Network
